Latisse
Learn more about Latisse
The only FDA approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
The onset of effect with Latisse solution is gradual. In the clinical trial , the majority of Latisse users saw a significant improvement by 2 months.
Since its FDA approval in December, 2008, Latisse® has become one of the highest rated cosmetic treatments according to consumer surveys. Thanks to proven efficacy, excellent safety record, and enthusiastic support of its user and spokesperson, actress Brooke Shields, Latisse® is now one of the most requested beauty treatments in the U.S. Like many medical breakthroughs, eyelash enhancement with Latisse® had its beginnings as an accidental discovery. The active ingredient in Latisse®, bimatoprost solution has originally been prescribed as eye drops for glaucoma patients. In time, those using this medication discovered that their eyelashes grew longer, thicker and darker. After years of development, Allergan formulated an application method to deliver bimatoprost solution directly to the eyelashes while safely keeping it out of the eye. Such discovery paved the way for development of Latisse®. This prescription-only solution is applied nightly with sterile applicators (provided) to the upper eyelid margin at the base of the eyelashes after make-up removal. In approximately eight weeks, one can expect thicker, longer and darker eyelashes. Our patients are absolutely delighted with the results!
Click here for a flyer
Click here to inquire about Latisse
Below is a before and after presentation
Learn more about Latisse
The only FDA approved prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker, and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.
The onset of effect with Latisse solution is gradual. In the clinical trial , the majority of Latisse users saw a significant improvement by 2 months.
Since its FDA approval in December, 2008, Latisse® has become one of the highest rated cosmetic treatments according to consumer surveys. Thanks to proven efficacy, excellent safety record, and enthusiastic support of its user and spokesperson, actress Brooke Shields, Latisse® is now one of the most requested beauty treatments in the U.S. Like many medical breakthroughs, eyelash enhancement with Latisse® had its beginnings as an accidental discovery. The active ingredient in Latisse®, bimatoprost solution has originally been prescribed as eye drops for glaucoma patients. In time, those using this medication discovered that their eyelashes grew longer, thicker and darker. After years of development, Allergan formulated an application method to deliver bimatoprost solution directly to the eyelashes while safely keeping it out of the eye. Such discovery paved the way for development of Latisse®. This prescription-only solution is applied nightly with sterile applicators (provided) to the upper eyelid margin at the base of the eyelashes after make-up removal. In approximately eight weeks, one can expect thicker, longer and darker eyelashes. Our patients are absolutely delighted with the results!
Click here for a flyer
Click here to inquire about Latisse
Below is a before and after presentation
